mdlinx mdlinx
Latest (45) Full Text Articles (1939) Focus on Atopy Article Summary

Comparative efficacy of indacaterol in chronic obstructive pulmonary disease Full Text
International Journal of COPD,  Clinical Article

Ribeiro M et al. – Data from trials with the novel once–daily β2–agonist, indacaterol, indicate superior bronchodilation and clinical efficacy over twice–daily long–acting β2–agonists and at least equipotent bronchodilation as once–daily tiotropium. Bronchodilators are central in the symptomatic management of chronic obstructive pulmonary disease (COPD). It is likely that once–daily dosing of a bronchodilator would be a significant convenience and probably a compliance–enhancing advantage, leading to improved overall clinical outcomes in patients with COPD.

  • Long–acting bronchodilators have been shown to improve multiple clinical outcomes in chronic obstructive pulmonary disease (COPD) including lung function, symptoms, dyspnea, quality of life, and exacerbations.
  • Indacaterol is a novel, inhaled, long–acting β2–agonist providing 24–hour bronchodilation with once–daily dosing.
  • It is currently approved for the maintenance treatment of COPD to be administered as 150 or 300 µg once–daily doses as licensed in many countries and 75 µg as licensed in the US by means of a single–dose dry powder inhaler.
  • The data from clinical development support a favorable safety and tolerability profile within the β2–agonist drug class, with no relevant issues identified.
  • Current evidence indicates that indacaterol is suitable for use as first–line monotherapy in COPD patients with moderate disease (Global Initiative for Chronic Obstructive Lung Disease [GOLD] stage II) and beyond that do not require an inhaled corticosteroid (ICS) as per GOLD guidelines, or in combination with an ICS in severe or very severe patients with repeated exacerbations.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Pulmonology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Pulmonology Articles

Last month's top read Top Articles of 2013

Indexed Journals in Pulmonology: Chest, Thorax, American Journal of Respiratory and Critical Care Medicinemore

Other Topics in Pulmonology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow
Like

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close